EconDefense
ACQ-29 / Intellectual property and technology transfer

Buy patents, copyrights, software, technical data and infringement releases

Acquire ownership/licensing rights, technical/design/process data and software useful to military-department supplies or processes, including releases for past infringement.

Authority / instrument · ACQ-29

Intellectual property & technology transfer

Intellectual property and technology transfer

Statute & instrument
Authority holder

Military-department authorities spending eligible supply-procurement funds

What this does not authorize / hard limit

Buying an item does not automatically buy its IP, source code or manufacturing data.

Recorded executor

Warranted contracting officer and program manager

Continue to actor →

Recorded executing role; this record-specific route is not an additional institutional office.

Legal basisSources linkedLegal sources and instrument limits are recorded.
RequirementsGates recordedRead the requirements for this instrument; applicability depends on the proposed action.
Public fundingRules recordedAppropriations available for making or procuring supplies may be used. Office budget figures are separate institutional context, not an allocation to this instrument.
Assigned rolesRoles recordedPublic sources describe institutional authority. The instrument identifies approval and execution roles; a specific signature remains transaction-dependent.
EngagementProcess sourcedPublished Army rules name authorized organizations and patent-counsel routing for IP purchases under section 3793. The 2026 regulatory restructuring requires contract-specific reconciliation. Program check: 2026-10-04; see each route for intake status.

Public evidence describes the institution and instrument; it is not approval of an individual transaction.

At a glance

Possible toolACQ-29 · Licensing & IP
Legal basis10 U.S.C. §3793

Authority holder: Military-department authorities spending eligible supply-procurement funds

Licensing & IP

Mechanism tags describe the source text; they do not expand the authority.

Availability and verification

Express statutory pathway; award-specific appropriations, available balances, delegations, implementation and approvals not independently verified.

Program process and intake

Checked 2026-10-04 · process documented. Program evidence is separate from legal authority, available funds and transaction approval.

Published Army rules name authorized organizations and patent-counsel routing for IP purchases under section 3793. The 2026 regulatory restructuring requires contract-specific reconciliation.

Army negotiated patent/copyright acquisition and claim release

Who this route serves
Government buyers and owners of relevant intellectual property
Administering office / routing lead
Named Army organizations and supporting chief patent counsel; other activities through specified written approval
Direct implementation

AFARS 5127.7011 expressly cites section 3793 and identifies the organizations permitted to acquire rights or settle related claims.

What this evidence label means
Published Army route; current clause reconciliation needed

The AFARS page effective July 11, 2025 remains published. The 2026 DoD deviation reserves former subpart 227.70, so legacy forms must be checked against current requirements.

Status reference date: 2026-10-04 · research checked 2026-10-04

DoD RFO Part27 class deviation2026-O0036 · Effective February 1, 2026; Attachment 227.70 reserved; 227.71–72official acquisition class deviation · Evidence record

Program eligibility

  • Proposed license/assignment communications go promptly to supporting patent counsel; other activities need the specified written approval unless an express exception applies.

    AFARS5127.7011 procurement of IP rights · Delegated organizations; written approval; patent-counsel routingofficial Army acquisition regulation · Evidence record

Steps and preparation

  • Define required rights and covered claims; obtain counsel review, required approval and a negotiated written license/release.

    AFARS5127.7011 procurement of IP rights · Delegated organizations; written approval; patent-counsel routingofficial Army acquisition regulation · Evidence record
Funding, limits and authority relationship

Funding and financial terms

  • negotiated acquisition/settlement consideration · contract-specific

    Purchase/license consideration is transaction-specific; no generalIP acquisition fund or available balance verified.

    AFARS5127.7011 procurement of IP rights · Delegated organizations; written approval; patent-counsel routingofficial Army acquisition regulation · Evidence record

Exclusions and limits

Authority relationship source

AFARS5127.7011 procurement of IP rights · Delegated organizations; written approval; patent-counsel routingofficial Army acquisition regulation · Evidence record

Army IP-rights acquisition routing →

published guidance: Negotiation through contracting/patent counsel, not a public startup-funding application.

Research scope and sources checked

Read exact Army 3793 implementation and current DoD Part 27 deviation; noted obsolete-subpart restructuring instead of assuming the old form package remains controlling.

What remains unverified

  • No executed3793 license/settlement amount independently verified; confirm current delegated approval and contract text afterRFO.

A dated source check is not continuing monitoring. Recheck the linked official notice before preparing a submission. Browse program research →

Requirements and limits

Eligibility & prerequisites

  • Acquisition relates to supplies/processes produced, used or useful to the military department.
  • Negotiate precise data, patent, copyright and software rights needed.

Limits & exclusions

  • Buying an item does not automatically buy its IP, source code or manufacturing data.
  • Release of past claims is distinct from unrestricted future commercial exploitation.

Funding conditions

  • Appropriations available for making or procuring supplies may be used.

Read the funding and execution guide

Who contributes what

Need & planning

  • Operational requirement owner; Service/component portfolio acquisition executive and program manager

Resources

  • Sponsoring Service/component appropriations manager and comptroller

Approval

  • Service/component acquisition executive and authorized contracting authority, at applicable threshold

Execution

Partners & review

  • User command
  • Counsel, fiscal, engineering, testing, logistics and security staff as applicable

Office links are editorial matches to the original role text, not verified delegations. Composite labels and unmatched actors are preserved.

Coordination pathway

Program defines rights/deliverables → Service IP counsel and contracting officer → valuation/licensing negotiation → funded agreement.

Actor and execution-role sources

What this research establishes

Legal basisSources linkedLegal sources and instrument limits are recorded.
RequirementsGates recordedRead the requirements for this instrument; applicability depends on the proposed action.
Public fundingRules recordedAppropriations available for making or procuring supplies may be used. Office budget figures are separate institutional context, not an allocation to this instrument.
Assigned rolesRoles recordedPublic sources describe institutional authority. The instrument identifies approval and execution roles; a specific signature remains transaction-dependent.
EngagementProcess sourcedPublished Army rules name authorized organizations and patent-counsel routing for IP purchases under section 3793. The 2026 regulatory restructuring requires contract-specific reconciliation. Program check: 2026-10-04; see each route for intake status.

Confidence: High on express authority and cited conditions; execution assignment is illustrative unless statute expressly names it.

Currentness: GovInfo 2024 Code (includes FY2025 NDAA, P.L. 118-159) read in full for cited provision; targeted FY2026 NDAA P.L. 119-60 amendment/repeal sweep. No claim of complete legislative currency through 2026-10-02; remaining 2026 delta needs counsel validation. OLRC indexed §3793 text dated 2026-09-27.

Review scope: Original research target October 2, 2026; no record-specific last-review date supplied. Publication is not legal-currentness certification.